Surbhi Sarna's Collate raises $95 million to automate life sciences paperwork

Redpoint led the round at a valuation Forbes says is nearing $1 billion, 17 months after Collate came out of stealth.

By · Published

Primary source: Forbes

Why it matters

Collate's round shows investors are hunting for the next vertical AI category after legal. In life sciences, the upside is huge, but so is the burden of proving AI can speed paperwork without weakening regulatory controls.

Illustration of Surbhi Sarna's company Collate organizing life sciences research documents and paperwork on a schematic grid.

Surbhi Sarna and Nate Smith's Collate has raised $95 million to automate life sciences documentation, at a valuation "approaching $1 billion," Forbes reported.…

Reader comments

Conversation for this story loads after sign-in.